Seems perfectly reasonable to me. I don't see the contradiction. Now that they know more, it may be brought to account for the full year, or they may choose to wait until the next half yearly, when they already have several months of Nullagine operation behind them.
In any case, at current projected production the deferred consideration is not going to fall due until FY2027 at the earliest.
All IMO.
Ann: Maiden Resource to underpin Nullagine Restart, page-114
Add CAI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CAI (ASX) Chart |
Day chart unavailable